Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers
Clinical trial NCT03023787 · COMPLETED
Trial details
- NCT number
- NCT03023787
- Sponsor
- Shanghai HEP Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2016-12-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.